| Previous close | N/A |
| Open | N/A |
| Bid | N/A |
| Ask | N/A |
| Strike | N/A |
| Expiry date | N/A |
| Day's range | N/A - N/A |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireOrganigram Invests in Sanity Group, a Leading German Cannabis Company
TORONTO, June 25, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its first significant strategic investment aimed at expanding its presence in the European cannabis market. Using proceeds from its Jupiter strategic investment pool, the Company has agreed to invest €14 million (~ C$21 million) initially comprised of €11.5 million via an unsecured convertible note and €2.5 million to purchase
Business WireOrganigram Signs Three Year Supply Agreement with Avida Medical in UK
TORONTO, May 28, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and specials medicines manufacturing business.
Business WireOrganigram Reports Second Quarter Fiscal 2024 Results
TORONTO, May 14, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the second quarter ended March 31, 2024 ("Q2 Fiscal 2024").
